In search of the perfect SERM: beyond tamoxifen and raloxifene.
C
C
McNeil
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000517:prevention & control; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000378:metabolism* / Q000517:prevention & control; D010880:Piperidines / Q000494:pharmacology; D020849:Raloxifene Hydrochloride; D011960:Receptors, Estrogen / Q000187:drug effects*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000494:pharmacology
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D010880:Piperidines; D011960:Receptors, Estrogen; D013629:Tamoxifen; C038345:droloxifene; D020849:Raloxifene Hydrochloride